Remix Therapeutics Inc., a company developing small molecules to manipulate RNA processing, stands to earn upward of $1 billion through a new strategic collaboration with Janssen Pharmaceutica NV. A ...
Imaging techniques such as ultrasound technologies and minimally invasive procedures are powerful tools for assessing pregnancy health and progression. However, a detailed, ongoing assessment of the ...
Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a deal with Merck KGaA aimed at discovering small-molecule RNA-targeted drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback